CD14 and neoplasm: Lastly, while we used multiplex immunofluorescence to validate the presence of CD14+APOE+ cells and MMP7+ tumour cells, additional validation using other complementary techniques such as flow cytometry or single‐cell RNA sequencing could provide a more robust confirmation of our findings.